NEWSROOM

FDA

YEP enters into Globally Exclusive Distribution Agreement for Axiom8, an FDA Clinically Approved 5-Hour skin protectant against Covid-19

Apr 16, 2021

  Leawood, Kansas, April 16, 2021 – -- YEP, Inc., (“YEP”), an innovative sales and marketing company, announced today that it has entered an exclusive global distribution agreement with Wellness Labs LLC for the manufacture and supply of Axiom8, a new, non-alcohol 5-hour clinically proven skin protectant for both consumer protection and workplace use in all global markets. Rick Anson, CEO of Wellness Labs and YEP VP of Product Innovation commented, “Axiom8 is a game changer for both...

read more

Enerkon Solar International (ENKS) Announces the Appointment of Famous Political Strategist and Consultant Mr. Agustin (GUS) Garcia as VP for Governmental Relations

Apr 14, 2021

  New York, New York, April 14, 2021 - - Enerkon Solar International (OTC Pink. ENKS) announces today the appointment of Famous Political Strategist and Consultant Mr. Agustin (GUS) Garcia as VP for Governmental Relations.     Mr. Agustin (GUS) Garcia Enerkon Solar International Inc. (ENKS) Chairman Mr. Benjamin Ballout Stated: "The company is pleased to announce the Appointment of Famous Political Strategist and Consultant Mr. Agustin (GUS) Garcia as VP for Governmental...

read more

InnerScope Hearing Technologies (INND) Completes FDA Class II Medical Device Registration for its Hearing Aid Devices

Mar 3, 2021

  InnerScope has completed the FDA Medical Device Registration for Class II Hearing Aid, Air Conduction with Wireless Technology, and is preparing for theLaunch ofits Latest in Direct-to-Consumer Hearing Aid Technology with its Smartphone App-ControlledSelf-Fitting– Self-AdjustingRechargeable Hearing Aids   ROSEVILLE, CA, March 3, 2021 -- --  InnerScope Hearing Technologies Inc. (OTC Pink: INND) ("InnerScope") announced today it has completed and updated the FDA Medical Device...

read more

PAOG Advances FDA Application Process For Respiratory Cannabis Drug Treatment

Oct 20, 2020

Sandusky, OH – October 20, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced the company plans to release a new key update this Friday, October 23, 2020, on its progress to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA).  PAOG announced last week that it anticipates soon entering into an agreement with a contract research organization (CRO) making a major breakthrough in advancing PAOG’s RespRx treatment for Chronic Obstructive...

read more

SinglePoint enters JV agreement to further expand and accelerate opportunities due to increased new client (Retail and B2B) demand in Hand Sanitizer market with Simplex + Virus Killer

Aug 7, 2020

Worldwide Hand Sanitizer Market to cross USD 3.6 Bn by 2026 Phoenix, Arizona, April 28, 2020 - SinglePoint Inc. (OTCQB: SING) ramping up effort to meet in bound demand for hand sanitizer and other sanitizing products. The company recently entered into an LOI that quickly progressed to a JV Agreement with Box-Bioscience. The agreement will provide both parties with the capability to enhance supply and expand sales opportunities of hand sanitizer. The product is current sold in a variety of...

read more

KALY – Kali-Extracts Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements

Aug 7, 2020

    Dallas, TX – Sep 4, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company has received a formal proposal to take one or more of its proprietary CBD extracts derived from the company’s U.S. Patented Extraction Process through a Current Good Manufacturing Practices (cGMPs) certification process for the purpose of certifying the extract as an Over-The-Counter (OTC) drug under the requirements prescribed by the U.S. Food and Drug...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »